» Articles » PMID: 15565801

Dynamic Magnetic Resonance Imaging of Tumor Perfusion. Approaches and Biomedical Challenges

Overview
Date 2004 Nov 30
PMID 15565801
Citations 46
Authors
Affiliations
Soon will be listed here.
Citing Articles

Evaluating dynamic contrast-enhanced MRI for differentiating HER2-zero, HER2-low, and HER2-positive breast cancers in patients undergoing neoadjuvant chemotherapy.

Hu Y, Li M, Hu Y, Wang M, Lin Y, Mao L Eur J Med Res. 2025; 30(1):132.

PMID: 40001120 PMC: 11852569. DOI: 10.1186/s40001-024-02188-6.


Structural and practical identifiability of contrast transport models for DCE-MRI.

Conte M, Woodall R, Gutova M, Chen B, Shiroishi M, Brown C PLoS Comput Biol. 2024; 20(5):e1012106.

PMID: 38748755 PMC: 11132485. DOI: 10.1371/journal.pcbi.1012106.


Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.

Kim J, Kim J, Suh H, Hwangbo L, Lee N, Kim S Eur Radiol. 2021; 32(2):822-833.

PMID: 34345946 DOI: 10.1007/s00330-021-08166-4.


Texture Analysis Using Semiquantitative Kinetic Parameter Maps from DCE-MRI: Preoperative Prediction of HER2 Status in Breast Cancer.

Song L, Li C, Yin J Front Oncol. 2021; 11:675160.

PMID: 34168994 PMC: 8217832. DOI: 10.3389/fonc.2021.675160.


Current status and future prospective of focal therapy for localized prostate cancer: development of multiparametric MRI, MRI-TRUS fusion image-guided biopsy, and treatment modalities.

Shoji S, Hiraiwa S, Hanada I, Kim H, Nitta M, Hasegawa M Int J Clin Oncol. 2020; 25(4):509-520.

PMID: 32040781 DOI: 10.1007/s10147-020-01627-8.